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Abstract
The diagnosis of American tegumentary leishmaniasis (ATL) still requires the design of
more effective tools. Leishmania (Viannia) braziliensis is the causal agent of the 90% of
Argentinean ATL cases. Considering the current knowledge, an ELISA based crude antigen
(CA) for the diagnosis was designed. Ninety-nine subjects diagnosed as ATL, 27 as no-
ATL, and 84 donors from non-ATL-endemic areas were included in this study. The current
ATL diagnosis was based four techniques, dermal smear microscopic examination (parasi-
tological test), PCR, Leishmanin skin test, and clinical records. We obtained CA extracts
from promastigotes and amastigotes from macrophage cultures of different zymodemes of
endemic Leishmania species circulating in the study area. Crude antigens from the ‘local’
main zymodeme of L. (V.) braziliensis showed the highest reactivity against anti-Leishmania
antibodies compared to the other included species. The CA of amastigotes of this zymo-
deme was 3.4 fold more reactive than promastigotes one. Moreover, amastigote-membrane
CA (MCA) were 3.6 fold more reactive than the soluble antigens. The MCA-ELISA reached
a sensitivity and specificity of 98% (CI = 94.7%-100%) and 63.6% (53.9–73.1), respectively.
When anti-Trypanosoma cruzi reactive sera were excluded, the specificity reached 98.4%
(94.4–100), while the sensitivity was similar, with a positive predictive value (PV) of 98.6%
(94.6–100) and negative PV of 96.3% (91.6–100). The performance of the MCA-ELISA
results strongly contribute to the final diagnostic decision, since a non-reactive serological
result almost discards the suspected ATL, because of its high negative PV. The developed
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MCA-ELISA showed a high diagnostic performance, which makes it a good candidate for
ATL diagnosis, for seroprevalence studies, or for monitoring treatments efficacy.
Introduction
Leishmaniasis is a group of diseases caused by various species of protozoa (Kinetoplastida: Try-
panosomatidae) of the genus Leishmania. Its transmission occurs when a female phlebotomine
sand fly infected with Leishmania spp. bites a potential host. The clinical manifestations
depend mainly on the parasite species and the host’s genetic and immunological constitution
[1, 2].
American tegumentary leishmaniasis (ATL) is an endemic disease in Argentina. The main
etiological agent in the country is Leishmania (Viannia) braziliensis, with L. (Leishmania) ama-
zonensis and L. (V.) guyanensis as the minor prevalent species in the endemic areas [3, 4]. In
fact, more than 90% of the ATL cases have been caused by L. (V.) braziliensis [5]. The preva-
lence of this species in this areas was later confirmed by nested PCR and sequencing of cyto-
chrome b (cyt b) gene [6].
The estimated incidence of ATL in Argentina reached 8.76 cases/year/106 inhabitants, cal-
culated from 1984 to 2005 case-reports [7], and 53.1% of the cases occurred in the north of
Salta province. Since the diagnosis of ATL in the country depends mainly on the visualization
of amastigotes in smears obtained directly from lesions, and other laboratory resources for
confirming the cases are not always available, the incidence values might be underestimated or
inaccurate. In addition, the time consuming microscopic technique (parasitological test) often
shows low sensitivity and requires highly trained personnel [8]. The Leishmanin skin test
(LST) is applied as complementary diagnostic test. However, it detects past infections or previ-
ous contact with the parasite, but not necessary an undergoing infection [4]. Furthermore, this
geographic area is endemic for Trypanosoma cruzi, another member of the Trypanosomatidae
family, which frequently shows cross reactivity with Leishmania spp. in different diagnosis
techniques, leading to misdiagnosis, misinterpretation of epidemiological data, and to difficul-
ties in disease treatment [4, 9].
Besides these methods, PCR has been an alternative approach to ATL diagnosis and Leish-
mania genus typing. In this way, a polymorphic specific-PCR (PS-PCR) approach developed
and directly applied on clinical samples, and the sequencing of cytb gene have shown promis-
ing results [5, 10]. However, these techniques are difficult to apply in rural health centers of
endemic areas, because of the technical requirements and the relatively high cost, which still
limit its routine use [11].
The diagnostic methods based on the detection of parasite specific antibodies have played
an important role in the diagnosis of many parasitic diseases, mainly owing to the relatively
low cost, high performance, high reproducibility, and low time consuming. In particular, now-
adays ELISA is commonly used to diagnose visceral leishmaniasis (VL) and also has a higher
sensitivity for ATL diagnosis than parasitological tests [12]. However, the general belief has
been that serological assays for ATL/cutaneous leishmaniasis (CL) would be limited by low
sensitivity, and consequently, they have not been considered for routine. Such a low diagnostic
performance reported, could be related to lack of the optimized and/or standardized condi-
tions of ELISA [13].
In this work, we analyzed the serological reactivity of different crude antigenic (CA)
extracts of Leishmania spp. in order to develop an ELISA method suitable for the diagnosis of
ATL. They were selected based on the current epidemiological, biological, and molecular
information on the parasites of the genus Leishmania in the current study areas.
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Materials and methods
Subjects and diagnosis of American tegumentary leishmaniasis
One hundred and twenty six patients with cutaneous or mucocutaneous lesions suspected of
leishmaniasis were included in this study. They were recruited between 2000 and 2014. The
diagnosis of ATL was performed in several institutions located in Salta province, Argentina by
a criterion consisting in a parallel combination of methods previously described [5]. Briefly,
they consist on the search for Leishmania amastigotes on smears of dermal scrapings, PS-PCR,
LST, and the analysis of clinical features of the patients.
The anamnesis, biological sampling for parasitological and molecular diagnosis of ATL,
and LST, were performed as previously described [5]. In addition, approximately five mL of
peripheral blood were aseptically taken by puncture-aspiration of the antebraquial vein. Serum
was separated by centrifugation at 3500 rpm for 10 min., and kept at -20˚C until use for the
serological reaction.
All patients diagnosed in the present work as ATL cases were systemically treated with 10–
20 mg d−1 kg body wt−1 of pentavalent antimony over 25–30 days. In the cases of incomplete
clinical cure, another treatment-cycle of the same extension with antimony or amphotericin B
was given. Treatments and clinical follow-up were conducted by local physicians at the differ-
ent medical institutions in Salta, Argentina, under the patients’ informed consent [5].
In addition, 40 sera from Chagas disease patients without tegumentary lesions were
included in the study. They were recruited in the same period mentioned previously. Those
patients inhabited in an endemic area of Argentina for this pathology. They were reactive for
two serological methods, a recombinant ELISA and an indirect hemaglutination test (IHA) for
the detection of anti-T. cruzi antibodies, as it was described previously [14].
The set of samples was completed with 44 sera of healthy donors from Japan, a non-
endemic area for either leishmaniasis or Chagas disease. These samples were kindly given by
the diagnosis laboratory of Kochi Medical School Hospital on 2007. (Fig 1).
Parasites and antigenic extracts
Three Argentinean and two World Health Organization (WHO) reference strains of Leish-
mania, previously characterized by multilocus enzyme electrophoresis, were included in this
study (Table 1). Mass cultures of promastigotes of each strain were obtained, harvested and
frozen following the procedures described previously [3].
Fig 1. Groups of patients included in this study. It was defined the cases or non-cases of American Tegumentary Leishmaniasis (ATL) from suspected patients by four
diagnostic methods mentioned above. Three of those 129 subjects were inconclusive and could not be grouped. Additionally, for the non-ATL cases, there were
included two groups of donors without ATL suspicion: Chagas seropositives and Japanese donors from non-endemic geographic area for ATL and Chagas disease.
https://doi.org/10.1371/journal.pone.0232829.g001
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Intracellular amastigotes of L. (V.) braziliensis (MHOM/AR/02/OLO1) corresponding to
KMS1, the main Argentinean zymodeme, were isolated from J774.1 cell line (RCB No. 0434.
Riken Bio Resource Center, Saitama, Japan). Briefly, macrophages were cultured with com-
plete RPMI 1640 medium (Nissui Pharmaceutical Co. Ltd, Japan) supplemented with 10% of
heat-inactivated fetal bovine serum, 200 mM of L-glutamine, 50 mg/mL of streptomycin and
100 U/mL of penicillin, and placed at 37˚C in a 5% CO2 95% air mixture. Cells were infected
with metacyclic promastigotes at a ratio of 10 / 1 (parasites / macrophage) and incubated in
culture flasks at 34˚C in a 5% CO2 95% air mixture. The intracellular parasites were released
from the host cells by three shake cycles in a vortex mixer followed by centrifugation at 3500
rpm for 10 min. Finally, the amastigotes were separated from the debris with 28% of Percoll
(Sigma, St. Louis, USA) in phosphate-buffered saline (PBS), layered on 1 mL of 100% Percoll
and centrifuged at 7000 rpm for 30 min at 48˚C [15].
Soluble and membrane-enriched antigens were extracted from the promastigote and amas-
tigote pellets following the procedures described previouslywith slight modifications [16].
Briefly, the pellets were resuspended in cold 0.05 M Tris-HCL, pH 7.8, in the presence of pro-
tease inhibitors (Roche, Mannheim, Germany). The cells were disrupted by sonication. After
centrifugation the supernatant, named soluble crude antigen (SCA), was collected and the pre-
cipitate was treated with detergent/enzyme inhibitor mixture (1:1, v/v; 1.0% sodium dodecyl
sulfate) for 12 hr at 4˚C and centrifuged to remove final cellular debris. This supernatant was
named membrane crude antigen (MCA). All of them were diluted with cold 0.05 M Tris, pH
7.8 to 10 mg of protein/mL [17]. Fractions of SCA and of MCA were pooled, and all the prepa-
rations were stored at– 70˚C until use.
Enzyme-linked immunosorbent assay procedures
The procedure was slightly modified from that described previously [18]. Briefly, the plates
were sensitized overnight at 4˚C with 100 μL of the SCA or MCA diluted in Bicarbonate/car-
bonate coating buffer, pH 9.6 at different concentrations, between 9 and 0.04 μg/mL of total
protein. The optimal antigens concentration selected for each experiment is shown in the
results section. Unbound antigen was removed by washing the wells three times with washing
buffer, 0.05% Tween 20 in 0.01 M phosphate buffered saline, pH 7.0 (PBST). Two-hundred μL
of Blocking One reagent solution (Nacalaitesque, Kyoto, Japan) were used in order to block
non-specific binding reactions, following the manufacturer’s instructions. Serum samples
were diluted between 1/20 and 1/4860 in a solution of 1/20 of Blocking One reagent in PBS,
0.1% Tween 20. The optimal serum concentration selected for each experiment is shown in
the results section. One hundred μL of sera solution were added in each well and the plates
were incubated at 37˚C for one hour. After washing five times with PBST, 100 μL of goat-anti-
Table 1. Leishmania zymodemes used for the preparation of antigenic crude extracts.
Strain designation Species Zymodeme Cell stage
Argentinean strains
MHOM/AR/02/OLO1 L. (V.) braz KMS1 Amastigote, promastigote
MHOM/AR/02/CFO5 L. (V.) braz KMS2 Promastigote
MHOM/AR/99/JDM1 L. (V.) guy KMS4 Promastigote
Reference strains
MHOM/BR/75/M2904 L. (V.) braz KMS7 Promastigote
MHOM/BR/73/M2269 L. (L.) amaz KMS6 Promastigote
L. (V.) braz: Leishmania (Viannia) braziliensis; L. (V.) guy: L. (V.) guyanensis; L. (L.) amaz: L. (Leishmania) amazonensis.
https://doi.org/10.1371/journal.pone.0232829.t001
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human polyvalent Immunoglobulins (G, A, M)−Peroxidase conjugate (Sigma, St. Louis, USA),
diluted 1/500 in the same solution used in the previous step, were added to each well and the
plates were incubated at 37˚C for one hour. Substrate and stop solution were prepared by dis-
solving the OPD (o-Phenylenediamine Dihydrochloride) tablets and diluting H2SO4 respec-
tively, following the manufacturer’s instructions (Dako, Glostrup, Denmark). Absorbances
(ODs) were read by a spectrophotometer at 490 nm.
For detection of anti-T.cruzi antibodies, recombinant 3.0 Chagatest ELISA (Wiener Lab,
Rosario, Argentina) was applied to all sera included in the study by following maker’s proce-
dures indications. Under those conditions, the sensitivity (SE) and specificity (SP) reported
reached 99.3% and 98.7% respectively. The resultant reactive sera were tested by IHA (Wiener
Lab, Rosario, Argentina) and informed to local physicians, as it was described previously [14].
Data analysis
Leishmania crude extracts avidity for anti-Leishmania antibodies. The ODs values
obtained from ELISAs for comparisons of crude antigens (CA) from different zymodemes/
species of Leishmania, amastigotes versus promastigotes, or SCA versus MCA were tabulated
with Office Excel 2007 software (Microsoft Corporation, CA), and then analyzed with Graph-
Pad Prism 5.0 (GraphPad Software Inc., CA) as follows. First, D´Agostino-Pearson normality
test was applied to each data set. According with its results, the Wilcoxon signed rank test, or
an ANOVA with Dunn´s multiple comparison was applied, depending on the number of
groups compared. A p-value less than 0.05 was considered significant.
Diagnostic performance of ELISA with the selected crude antigens. The diagnostic per-
formance of the tests was assessed by calculating several statistical indicators, including SE, SP
and predictive values (PV). First the patients were classified into two groups: ATL cases and
non-ATL cases based on the presence or absence of the disease, diagnosed based on combina-
tion of methods, as it was described above (Fig 1). In order to dichotomize the ELISA resulting
ODs, a cut off value (CO) was established with the average of negative controls by the formula:
ODneg þ 6� SDneg . An indetermination area of ODs was consequently defined, as the interval
between CO±10% CO. For relativization proposes, the formula ODx=CO was applied, were
ODx is the average of duplicate or triplicate ODs for each sample tested. The indicators were
estimated applying Epidat 3.1 software. The PVs for the laboratory were calculatedby applying
the Theorem of Bayes assuming a prevalenceof 54.82% for the year 2005.The proportions SE,
SP and PVs were compared by Statistic-z analysis, using the same software [5, 19]. In addition,
a Receiver Operator Curve (ROC) analyze was performed applying the GraphPad Prism 5.0
software, GraphPad Software Inc., San Diego, CA.
Ethics statement
All patients and donors voluntarily consented to participate anonymously in this study. The
procedures and the informed consent forms, signed by the subjects, were approved by the Bio-
ethics Committee of the Medical College of Salta and thethe Bioethics Committee of the Health
Ministry of Salta, Argentina following the Declaration of Helsinki Principles. The last reevalua-
tion of projects including diagnosis of leishmaniasis was approved on 19th March, 2015.
Results
Antigen selection
A series of experiments were designed in order to find the most suitable Leishmania crude
antigenic extracts, according to their avidity for anti-Leishmania antibodies. For this purpose,
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a group of 17 to 22 sera, depending on each series experiment, from ATL-non Chagasic cases
described in Fig 1 was studied in the same ELISA plate in order to maintain constant all the
experimental conditions. Previously, the component concentrations and the conditions of
each reaction assay were precisely adjusted by double-titration assays [20]. Since none of the
data sets of the experiments passed the normality test, non-parametric tests were used for sta-
tistical significance estimation.
Antigens from ‘local’ L. (V.) braziliensis zymodemes have the highest avidity for anti-
Leishmania antibodies. In the first assay of the series, 17 sera from ATL-non Chagasic cases
were tested against crude antigenic extracts that were prepared from promastigotes cultures of
the five zymodemes, corresponding to the three species previously incriminated as the causal
agents of ATL in Argentina (Table 1) [3]. The ODs, ODs averages, and their statistical signifi-
cance (p< 0.05) are shown in Fig 2A. The resulting ODs of the sera from non-ATL patients
used as negative controls were similar to those from the blank one (data not shown). The SCA
plus MCA extracted from the zymodeme KMS1 of L. (V.) braziliensis, the prevalent species in
this endemic area, resulted in an average absorbance 1.85 fold higher than zymodeme KMS6
of L. (L.) amazonensis, which represents the minority species described in the area (Table 1)
[4].
Amastigote antigens are more efficient than promastigote ones in the anti-Leishmania
antibodies capture. In the next assay of the series, the efficiency of anti-Leishmania Igs cap-
ture between the different parasite cell stages was compared using 21 sera of ATL cases. To
assess this assay, antigens from intracellular amastigotes and promastigotes were obtained
from L. (V.) braziliensis KMS1 zymodeme expressing-strain, showing the highest avidity for
anti-Leishmania Igs in the previous assay. The amastigotes CA extract was 3.4 fold more effi-
cient than promastigote one in the anti-LeishmaniaIgs captured (Fig 2B).
The amastigote-membrane extracts are more reactive than the soluble ones. The assays
described above were performed by using a mix of SCA and MCA following the study reported
previously [15]. In this trial, the antigenic efficiency of both fractions was tested separately by
using 21 sera from ATL cases by ELISA. The MCA were 3.6 fold more reactive than the SCA
(Fig 2C). Then, the MCA was selected for its calibration and estimation of the diagnostic per-
formance of ATL.
Diagnostic performance of an ELISA for ATL with amastigote-membrane antigenic
extracts of Leishmania (Viannia) braziliensis. Once the MCA extract of L. (V.) braziliensis
amastigotes was selected, the optimal concentration ranges of the antigen, sera, and conjugates
were determined by double titration assays. To assess this, pools of 10 sera from patients with
presence or absence of ATL were used in the assays. Then, preliminary ELISA tests were car-
ried out with 45 sera from ATL or non-ATL groups in the same plate, at the following optimal
concentrations defined: [MCA] = 0.1 μg/well, [Sera] = 1/200, and [conjugate] = 1/500. A
serum from a patient with ATL was selected as positive, and six sera from non-ATL cases as
negative controls respectively for the following determinations. For dichotomization, a CO
and an indetermination area was established. Thus, the ODs determined for each patient
serum, located at this range, cannot be classified as reactive or non-reactive by the ELISA
employed, excluding the result of any diagnostic interpretation (Fig 3A and 3C).
The statistical indicators of diagnostics performance of the ELISA were estimated including
sera from 98 ATL cases and 107 non-ATL cases (Fig 1, Table 2). The ODs resulting of the
remaining five cases sera, 2.4%, were in the indetermination zone of the method, so they were
excluded from the indicators estimation. In addition, detection of anti-T.cruzi antibodies was
done on all sera of both group with recombinant Chagatest ELISA 3.0, a sensitive and specific
commercially available test (Fig 3A and 3C).
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The present ELISA procedure showed high SE and negative PV, and low SP and positive
PV. Nevertheless, they significantly increase when the reactive Chagatest ELISA patients were
excluded from the analysis (Table 2). The areas under the ROC curve were 0.84; p< 0.0001,
and 0.98; p<0.0001 showing the same effects of this exclusion (Fig 3B and 3D).
Fig 2. Comparison between the main local species, promastigoste vs. amastigote extracts and membrane based vs. soluble extracts. Comparison
between Optical Density (OD) for each ATL case and resultant absorbance means (ODm) obtained from the following three consecutive assays, showing
the differences among the avidity for anti-Leishmania antibodies. A) The ODs of 17 ATL cases and its ODm obtained by ELISA using promastigote Ags
of five Leishmania zymodemes (0.15 μg/well), sera (1/2000,100 μl/well), and conjugate (1/500) conditions [�p by ANOVA/Dunn´s multiple comparison
test vs. main local L. (V.) braz]; B) The ODs of 21 ATL cases obtained by using amastigote or promastigote Ags from Argentinean L. (V.) braziliensis
main zymodeme (0.15 μg/well), sera (1/2000,100 μl/well), and conjugate (1/500) [�p by Wilcoxon test]; C) The ODs of 21 ATL cases obtained by using
membrane or soluble extracts from amastigotes of Argentinean L. (V.) braziliensismain zymodeme under conditions previously described [�p by
Wilcoxon test]. A p-value less than 0.05 was considered significant.
https://doi.org/10.1371/journal.pone.0232829.g002
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Discussion
Serological methods are important diagnostic tools for several infectious diseases due to their
low cost and technical simplicity. In this work, an ELISA for ATL diagnosis has been designed
based on the current knowledge of the disease in endemic areas of Argentina. Thus, L. (V.)
braziliensis has been incriminated as the causal agent of 90% of ATL cases [5]. The first assay
Fig 3. Diagnostic performance of the selected antigenic extract. Enzyme Lynked Immunosorbent Assay reactivity
using the membrane amastigote extract against ATL and non-ATL cases sera Aand B, and excluding Chagatest
reactive samples, C and D. The relationODx / CO, whereODx is the average of duplicate or triplicate ODs for each
sample tested, and CO = Cut-off. The indetermination area (IA) is shown in dotted line, and defined as CO / CO±10%
CO / CO = 0,9–1,1. B and D show the Receiver Operating Characteristic (ROC) Curves for ELISAs.
https://doi.org/10.1371/journal.pone.0232829.g003
Table 2. The performance of ELISA using amastigote-membrane extracts of ‘local’ L. (V.) braziliensis as antigens.
ELISA Sensitivity Specificity PPV NPV No. of cases˚
Percent (CI, 95%) ATL NoATL
Total 98 (94.7–100) 63.6 (53.9–73.1) 76.5 (63.1–79.1) 96.3 (92.5–100) 98 107
Chagatest reactives excluded 96.9 (92–100) 98.4 (94.4–100)� 98.6 (94.6–100)� 96.3 (91.6–100) 65 61
PPV/NPV: Positive/negative predictive values. CI: Confidence intervals. ELISA conditions: Ag: 0.1 μg/well; sera (1/200,100 μl/well); conjugate (1/500) (�p < 0.05 vs.
total specificity and total PPV)
https://doi.org/10.1371/journal.pone.0232829.t002
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proves that the avidity for the anti-Leishmania antibodies of the S plus MCA differs with the
Leishmania species from which they were extracted. Thus, those CA obtained from local
zymodemes of the prevalent species showed the highest avidity. In this sense, it is consistent
also with the phylogenetic relationships of the genus Leishmania, as L. (V.) braziliensis is the
most avid, followed by a species from the same subgenus, L. (V.) guyanensis. Accordingly, the
S plus MCA from L. (L.) amazonensis, the most divergent LTA causal agents in the study area,
reached almost a half of those maximum avidities (Fig 2A) [6, 21]. These differences on the
species-specific epitopes avidity against anti-Leishmania antibodies was also observed in a
serological study in Brazil, where CA from L.(V.) braziliensis had more diagnostic power com-
pared to L. (L.) amazonensis one [22]. These differences could be attributed to a divergence at
the proteome more than at the genome level, due to the complex post-transcriptional and
post-translational regulation mechanisms of Leishmania genes [23, 24]. Thus, despite the few
genome differences among species [25], there is a broad phenotype disease, and a great spec-
trum of specific antigenic epitopes.
The amastigotes S plus MCA showed more than three times reactivity than the promasti-
gotes one (Fig 2B). The intracellular amastigote is the replicant-infective form of Leishmania
present in the mammalian host. The promastigote stage occurs only at the beginning of the
infection, until it is phagocytized by macrophagic-monocytic system cells [26]. Therefore, the
humoral immune response would be triggered, mainly on the antigens expressed by the amas-
tigote stage. However, further research is needed for understanding the bases for this antigenic
behavior.
In addition, the amastigote MCA resulted almost four folds more reactive than the SCA,
the highest difference observed in this work (Fig 2C). This result could be interpreted as fol-
lows; the membrane antigenic extract contains solubilized proteins with hydrophobic
domains, necessary for their biochemical interaction with membranes. These epitopes are
more immunogenic than the soluble ones, increasing the avidity for anti-Leishmania antibod-
ies in an in vitro test.
The most frequently used method to diagnose ATL at the public health systems in endemic
countries are the amastigote screening in smears of lesions and LST. However, both methods
have some intrinsic limitations: Amastigotes detection in the smears is invasive and has a low
sensitivity, particularly in ATL cases with chronic lesions, in wichthe number of parasites is
extremely low and became difficult to demonstrate the presence in the lesions [27]. While LST
does not distinguish between present and past infections, and thus its importance as a diagnos-
tic tool is questionable for people living in endemic areas [12]. In this context, the advantages
in diagnostic performance of the MCA included a higher sensitivity than the PS-PCR, dermal
smears, or the parallel-combination ones, tested independently and reported in a previous
study [5]. This serological method also resulted more sensible than those proposed for diagno-
sis of ATL so far. They are mainly based in CA extracts from promastigotes of Leishmania sub-
genus species, applied in areas where Viannia subgenus is prevalent [28]. Such a good good
performance is also reflected in this work by the high negative PV.
Regarding to specificity, it is only compromised by the cross reaction with the anti-T. cruzi
antibodies, since when the Chagasic patients are excluded from the analysis, it reaches to
98.4% (Table 2, Fig 3). Therefore, it was not affected by other endemic affections, or clinically
comparable to ATL cutaneous diseases, represented in the non-ATL group tested (Fig 3).
Anti-Leishmania antibody detection in sera of patients also provides an independent and
complementary result to the methods performed with material from the ATL lesions. This fact
is relevant in cases when it is difficult to collect appropriated biological material from the
lesions, because of their anatomical location, as in the case of secondary mucosal lesions, or
because the sample extraction is painful due to a bacterial secondary infection.
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Thus, the ELISA results influence the final medical decision, since a non-reactive one
almost discard the suspected ATL, because of its high negative predictive value, (Table 2). In
case of a reactive result, it indicates the presence of the disease only in non-Chagasic patients
or in non-endemics areas of Chagas disease.
In conclusion, the current CA-based ELISA has demonstrated to be a method of high diag-
nostic performance, which makes it as good candidate for the diagnosis, seroprevalence stud-
ies, or for monitoring treatments of ATL, and design of defined antigens in further studies.
However, in endemic areas of Chagas disease, the ATLdiagnosis has to be combined with sero-
diagnosis for the correct interpretation of the results.
Acknowledgments
We are grateful to Pedro Rueda, Marı́a E. Martina, Maria E. Garay, Marı́a D. Rango and all the
personnel of the Institute of Experimental Pathology (IPE), Faculty of Health Sciences,
National University of Salta / National Council for Technical and Scientific Research (CONI-
CET), for their technical contributions and valuable comments. We also thank the physicians
and personnel of the Department of Dermatology, Milagro Hospital and the Department of
Dermatology and Otorhinolaryngology, San Bernardo Hospital, Salta, for recruiting the
patients. Finally, we thank Wiener Lab, Argentina, for kindly providing the Chagatest kits
used in this study.
Author Contributions
Conceptualization: Marı́a E. Bracamonte, Agustı́n Moya Álvarez, Fernando J. Sánchez-Val-
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